Clinical trials
Phase 3 trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,165 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 17 |
| 2002 | 11 |
| 2003 | 30 |
| 2004 | 22 |
| 2005 | 37 |
| 2006 | 47 |
| 2007 | 40 |
| 2008 | 44 |
| 2009 | 56 |
| 2010 | 53 |
| 2011 | 44 |
| 2012 | 49 |
| 2013 | 57 |
| 2014 | 50 |
| 2015 | 64 |
| 2016 | 38 |
| 2017 | 63 |
| 2018 | 56 |
| 2019 | 57 |
| 2020 | 40 |
| 2021 | 52 |
| 2022 | 55 |
| 2023 | 51 |
| 2024 | 37 |
| 2025 | 42 |
| 2026 | 22 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 771 |
| Active, not recruiting | 142 |
| Terminated | 118 |
| Recruiting | 102 |
| Unknown status | 22 |
| Enrolling by invitation | 7 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 78 |
| Merck Sharp & Dohme LLC | 58 |
| Boehringer Ingelheim | 50 |
| GlaxoSmithKline | 46 |
| AbbVie | 42 |
| Children's Oncology Group | 41 |
| Pfizer | 33 |
| Gilead Sciences | 31 |
| Janssen Research & Development, LLC | 27 |
| Amgen | 26 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 47 |
| Breast Neoplasms | 42 |
| Pulmonary Disease, Chronic Obstructive | 38 |
| Crohn Disease | 33 |
| Arthritis, Rheumatoid | 32 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 31 |
| Neoplasms | 30 |
| Carcinoma, Non-Small-Cell Lung | 29 |
| Prostatic Neoplasms | 27 |
| Colitis, Ulcerative | 23 |
Trials
Showing 1 to 25 of 1,165. Each trial links to its page on Pharma Observatory.
1,065 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.